US Patent Issued to Biolinq on June 24 for "Method for improved sensor sensitivity of a microneedle-based continuous analyte monitoring system" (California Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,336,816, issued on June 24, was assigned to Biolinq Inc. (San Diego).

"Method for improved sensor sensitivity of a microneedle-based continuous analyte monitoring system" was invented by Alan Steven Campbell (La Mesa, Calif.), Robert McKinlay (San Marcos, Calif.) and Shuai Xu (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are variations of an analyte monitoring system, including an analyte monitoring device. For example, an analyte monitoring device may include an implantable microneedle array for use in measuring one or more analytes (e.g., glucose), such as in a continuous manner. Each microneedle of the microneedle array m...